RAS mutation status in colorectal cancer

Speaker: Marc Peeters

Marc Peeters interpret results of expanded RAS analysis in the CRYSTAL and OPUS studies in metastatic colorectal cancer and post-hoc analysis of KRAS status in the adjuvant PETACC8 trial.

Discussion Points

  • OPUS - Extended RAS analysis
  • Do biomarkers have a prognostic role in the adjuvant setting?